Document is current
Any future updates will be listed below
-
Authors
Delvert, Rosalie https://orcid.org/0000-0002-1524-8071
Charles, Marie-Aline https://orcid.org/0000-0003-4025-4390
Leynaert, Bénédicte https://orcid.org/0000-0001-5045-2492
Kadawathagedara, Manik https://orcid.org/0009-0002-3363-6219
Adel-Patient, Karine https://orcid.org/0000-0002-2242-0626
Divaret-Chauveau, Amandine https://orcid.org/0000-0002-2492-9864
Dufourg, Marie-Noëlle https://orcid.org/0000-0002-4209-934X
Raherison, Chantal https://orcid.org/0000-0003-0015-2883
Varraso, Raphaëlle https://orcid.org/0000-0002-3338-7825
de Lauzon-Guillain, Blandine https://orcid.org/0000-0001-5887-8842
Bédard, Annabelle https://orcid.org/0000-0002-7842-8889
-
Funding
Funding for this research was provided by:
Agence Nationale de la Recherche (ANR-19-CE36-0008)
- License Information
-
More Information
Article History
Received: 17 March 2024
Accepted: 29 May 2024
First Online: 6 June 2024
Competing interests
: R. Delvert declares no competing interests. M.A. Charles declares no competing interests. B. Leynaert declares no competing interests. M. Kadawathagedara declares no competing interests. K. Adel-Patient declares no competing interests. A. Divaret-Chauveau, outside of the submitted work, reports grants from the French public agency ANSES, Don du Souffle, Novartis, ARAIRLOR, consulting fees for Sanofi, Stallergens, ALK, Aimmune Therapeutics, payment for presentations for Aimmune Therapeutics, Novartis, ALK, support for attending meetings from Mead Johnson, Nutricia, Aimmune Therapeutics, Novartis, ALK, stocks from Essilor Luxottica. M.N. Dufourg declares no competing interests. C. Raherison, outside of the submitted work, reports contracts from Sanofi, payment for presentations from Novartis, AstraZeneka, GSK, support for attending meetings from Sanofi, AstraZeneca, Sanofi, participation on Advisory Board of Sanofi. R. Varraso declares no competing interests. B. de Lauzon-Guillain declares no competing interests. A. Bédard declares no competing interests.
